Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
ACS Chemical Neuroscience
ISSN 1948-7193 · American Chemical Society · UNITED STATES · Biweekly · Founded 2010
ACS Chemical Neuroscience: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.48; transformative journal; APC about USD 4,500; median 103 days to acceptance (39 articles, last 24 months); 441 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ACS Chemical Neuroscience is published by American Chemical Society and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research and Receptor Mechanisms and Signaling, together about 35.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ACS Chemical Neuroscience reports chemical biological biophysical and bioengineering research on the nervous system and neurological disorders.
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Alzheimer's disease research and treatmentsMedicine14.6%
- Neuroscience and Neuropharmacology ResearchNeuroscience12.2%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology8.5%
- Cholinesterase and Neurodegenerative DiseasesMedicine5.9%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.5%
- Parkinson's Disease Mechanisms and TreatmentsMedicine4.9%
- Computational Drug Discovery MethodsComputer Science4.5%
- History and advancements in chemistryChemistry4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.48LetPub ·
- CiteScore 2026-06
- 6.9LetPub ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 54LetPub ·
- h-index
- 126OpenAlex ·
- i10-index
- 2,998OpenAlex ·
- 2-year mean citedness
- 4.24OpenAlex ·
- Self-citation rate
- 4.4%LetPub ·
- Share of gold OA articles
- 29.46%LetPub ·
Volume
- Articles per year
- 368LetPub ·
Articles by year OpenAlex count · 5,258 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 272 | 100 | 137 |
| 2025 | 441 | 172 | 1,416 |
| 2024 | 402 | 182 | 3,170 |
| 2023 | 423 | 176 | 5,573 |
| 2022 | 384 | 130 | 5,631 |
| 2021 | 447 | 140 | 9,685 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
103 daysMedian, submission to acceptance · P25–P75 72 days – 142 days
- Acceptance to online
- median 18 days (1 articles)
- Submission to online
- median 78 days
- Sample
- 39 articles with submission and acceptance dates (698 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Transformative journalLetPub
A subscription journal moving to full open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Chemical Society
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Biweekly
- Founded
- 2010
- ISSN
- 1948-7193
- Latest issue on the website
- Volume 17, Issue 17 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ACS Chemical Neuroscience
What CAS zone is ACS Chemical Neuroscience in?
In the 2025 upgraded edition of the CAS Journal Ranking, ACS Chemical Neuroscience is in Zone 3 of Medicine, and in Zone 2 of the minor category Biochemistry & Molecular Biology / Chemistry, Medicinal / Neurosciences. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ACS Chemical Neuroscience?
The latest impact factor listed by LetPub is 4.48; CiteScore 6.9, h-index 126.
How long does peer review take at ACS Chemical Neuroscience?
Based on the dates recorded on 39 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 103 days (interquartile range 72–142 days); authors report an average review time of 4–8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ACS Chemical Neuroscience?
According to LetPub and DOAJ records, ACS Chemical Neuroscience is indexed in SCIE and Scopus.
Is ACS Chemical Neuroscience open access, and what is the APC?
ACS Chemical Neuroscience is a transformative journal. APC about USD 4,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .